(Q41036904)

25 September 2017

1 reference

title

The ecology and pathology of Epstein-Barr virus (English)

1 reference

25 September 2017

0 references

Schmidt CW

1

1 reference

PubMed ID

8713470

25 September 2017

Misko IS

series ordinal

2

1 reference

25 September 2017

1 December 1995

1 reference

Immunology & Cell Biology

25 September 2017

1 reference

25 September 2017

73

1 reference

25 September 2017

6

1 reference

25 September 2017

489-504

1 reference

Epstein-Barr virus: adaptation to a life within the immune system

25 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Can Epstein--Barr Virus Infect and Transform All the B-Lymphocytes of Human Cord Blood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus associated B-cell lymphomas in AIDS and after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Intracellular forms of Epstein–Barr virus DNA in human tumour cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Unexpected patterns of Epstein-Barr virus gene expression during early stages of B cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The small RNAs of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Establishment of cell lines from peripheral leucocytes in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Pathogenesis of infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Primary epstein-barr virus infections in African infants. II. Clinical and serological observations during seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Culture of Normal Human Leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Transformation of Human Leucocytes by Throat Washing from Infectious Mononucleosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Oropharyngeal Excretion of Epstein-Barr Virus by Patients with Lymphoproliferative Disorders and by Recipients of Renal Homografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Site of Epstein-Barr virus replication in the oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus persistence and virus-associated tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Transmission of infectious mononucleosis by transfusion of pre-illness plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr-virus-coded thymidine kinase expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Antibodies against the large subunit of the EBV-encoded ribonucleotide reductase in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Cytogenetic characterization of Epstein-Barr virus-associated T-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

T-cell lymphoma and the virus-associated hemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Role of epithelium in EBV persistence and pathogenesis of B-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus in Hodgkin's disease and site of origin of tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Reactivation of Epstein-Barr virus in Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Occurrence of malignancy in immunodeficiency diseases. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Detection of a second widespread strain of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Prevalence of the A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from Southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus type B in patient with T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Geographical prevalence of two types of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

A Transformation-Incompetent, Nuclear Antigen 2-Deleted Epstein-Barr Virus Associated with Replicative Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Differential accumulation of herpes simplex virus type 1 latency-associated transcripts in sensory and autonomic ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Varicella-zoster virus transcription in human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Transformation-associated Epstein-Barr virus antigens as targets for immune attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Early events in Epstein-Barr virus infection of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Replication of EBV in epithelial cells during infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Immunological studies on the Epstein-Barr virus encoded alkaline deoxyribonuclease found in virus-producing lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus and its interaction with the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus gene expression in oral hairy leukoplakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr Nuclear Antigen (EBNA) Carrying Lymphocytes in Human Palatine Tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

Molecular evolution of herpesviruses: genomic and protein sequence comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Herpes simplex genes: the blueprint of a successful human pathogen

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

EB viral genomes in epithelial nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

EBV gene expression in an NPC-related tumour.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Induction of Epstein-Barr virus nuclear antigens

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Synchronous and sequential activation of latently infected Epstein-Barr virus genomes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Lymphocytic infiltrations of lip salivary glands in bone marrow recipients. A model for the development of the histopathological changes in Sjögren's syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FICB.1995.79

7 January 2021

Identifiers

DOI

10.1038/ICB.1995.79

1 reference

25 September 2017

1 reference

PubMed ID

8713470